Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...

Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon , a bookrunner said on Monday, ...

Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, ...

From US drugmaker Pfizer's stake sale in Sensodyne maker Haleon to Beijing joining the list of Chinese cities easing ...

Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...

Indian banks' loan growth moderated in August amid a slowdown in credit card debt and personal loans, central bank data ...

Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a bookrunner said on ...

Pfizer Inc. announced a further reduction of its stake in Haleon Plc, offering to sell about a 5.9% stake in the UK consumer ...

Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...

On completion, Pfizer, the New York-based pharmaceuticals firm, will see its interest in Haleon fall to just over 16% from 22.6% currently. Bloomberg reported that the share sale price is likely to be ...

Britain’s tax burden will likely stay at its 70-year high for decades, the director of a leading think tank has warned.